Swerdloff R S, Wang C, Bhasin S
Baillieres Clin Endocrinol Metab. 1992 Apr;6(2):451-83. doi: 10.1016/s0950-351x(05)80158-2.
Clinicians and clinical investigators have developed improved means for controlling testicular function in men. New and refined approaches for stimulation and inhibition of the hypothalamic-pituitary-testicular axis are now available. This chapter reviewed the most successful ways to inhibit the reproductive axis in men and its current application to the treatment of precocious puberty, metastatic prostate cancer, benign prostate hyperplasia and as prospective male contraceptives. Safe, effective and reversible medical approaches to male contraception are now approaching reality. Azoospermia and severe oligozoo/azoospermia can now be accomplished in the majority of men with combined GnRH antagonists and replacement doses of testosterone. Androgens and androgen-progestogen concentrations will induce azoospermia in over 90% of Asian men and azoospermia or severe oligospermia in Caucasian ethnic groups. Field trials are ongoing to determine whether testosterone administration will be more effective than condoms as contraceptives. True precocious puberty can now be managed more effectively than in the past by suppression of gonadotropin secretion with GnRH analogues. Precocious puberty due to other causes can be treated more effectively with inhibitors of steroidogenesis and blockers of androgen action. Metastatic prostate cancer, previously treatable with either castration or oestrogens, is now amenable to suppression of androgen secretion. GnRH analogues are given either alone or combined with blockers of androgen action. While significant palliative effects are observed with endocrine ablative therapy in most men with Stage C or D prostate cancer, modest increases in duration of survival may be seen. Benign prostate hyperplasia was previously approachable only with surgical intervention. Recent data have suggested that medical treatment with 5 alpha-reductase inhibitors and/or selective alpha-adrenergic blockers may offer non-surgical alternatives in some patients. More data are needed to determine the role of medical management of this common disorder.
临床医生和临床研究人员已经开发出了改善男性睾丸功能控制的方法。现在有了刺激和抑制下丘脑 - 垂体 - 睾丸轴的新的和改进的方法。本章回顾了抑制男性生殖轴最成功的方法及其目前在治疗性早熟、转移性前列腺癌、良性前列腺增生以及作为潜在男性避孕药方面的应用。安全、有效且可逆的男性避孕医学方法正在成为现实。现在,联合使用促性腺激素释放激素(GnRH)拮抗剂和睾酮替代剂量,大多数男性可以实现无精子症和严重少精子症/无精子症。雄激素和雄激素 - 孕激素浓度可使超过90%的亚洲男性出现无精子症,在白种人群体中可导致无精子症或严重少精子症。正在进行现场试验以确定睾酮作为避孕药是否比避孕套更有效。现在,通过使用GnRH类似物抑制促性腺激素分泌,可以比过去更有效地治疗真性性早熟。由其他原因引起的性早熟可以用类固醇生成抑制剂和雄激素作用阻滞剂更有效地治疗。转移性前列腺癌以前可用去势或雌激素治疗,现在可以通过抑制雄激素分泌来治疗。GnRH类似物可单独使用或与雄激素作用阻滞剂联合使用。虽然在大多数C期或D期前列腺癌男性患者中,内分泌消融治疗可观察到显著的姑息效果,但生存期可能会有适度延长。良性前列腺增生以前只能通过手术干预来治疗。最近的数据表明,在一些患者中,使用5α - 还原酶抑制剂和/或选择性α - 肾上腺素能阻滞剂进行药物治疗可能提供非手术替代方案。需要更多数据来确定这种常见疾病药物治疗的作用。